- Home
- ASRV vs VNRX Comparison
ASRV vs VNRX Comparison
Compare ASRV & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- VNRX
- Stock Information
- Founded
- ASRV 1983
- VNRX N/A
- Country
- ASRV United States
- VNRX United States
- Employees
- ASRV N/A
- VNRX N/A
- Industry
- ASRV Major Banks
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ASRV Finance
- VNRX Health Care
- Exchange
- ASRV Nasdaq
- VNRX Nasdaq
- Market Cap
- ASRV 40.3M
- VNRX 45.2M
- IPO Year
- ASRV N/A
- VNRX N/A
- Fundamental
- Price
- ASRV $2.40
- VNRX $0.50
- Analyst Decision
- ASRV
- VNRX Strong Buy
- Analyst Count
- ASRV 0
- VNRX 5
- Target Price
- ASRV N/A
- VNRX $3.75
- AVG Volume (30 Days)
- ASRV 20.5K
- VNRX 167.9K
- Earning Date
- ASRV 04-22-2025
- VNRX 05-20-2025
- Dividend Yield
- ASRV 4.96%
- VNRX N/A
- EPS Growth
- ASRV N/A
- VNRX N/A
- EPS
- ASRV 0.22
- VNRX N/A
- Revenue
- ASRV $53,037,000.00
- VNRX $1,233,511.00
- Revenue This Year
- ASRV N/A
- VNRX $563.72
- Revenue Next Year
- ASRV N/A
- VNRX $160.43
- P/E Ratio
- ASRV $11.17
- VNRX N/A
- Revenue Growth
- ASRV 16.87
- VNRX 59.10
- 52 Week Low
- ASRV $2.03
- VNRX $0.42
- 52 Week High
- ASRV $3.06
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- ASRV 52.50
- VNRX 47.94
- Support Level
- ASRV $2.35
- VNRX $0.46
- Resistance Level
- ASRV $2.46
- VNRX $0.54
- Average True Range (ATR)
- ASRV 0.10
- VNRX 0.04
- MACD
- ASRV 0.01
- VNRX 0.01
- Stochastic Oscillator
- ASRV 60.71
- VNRX 48.00
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.